Cardiac power output index to define hemodynamic response to Impella support in cardiogenic shock

Author:

Sern Lim Hoong1ORCID

Affiliation:

1. Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Abstract

Background: Early assessment of response to Impella in cardiogenic shock may guide escalation of mechanical circulatory support. Therapeutic goal and response to Impella have not previously been defined. This study tested the hypothesis that targeting 3-h post- Impella cardiac power output index (CPOi)—“hemodynamic response”—in cardiogenic shock is associated with 12-h lactate clearance. Methods: Single-center study of 37 consecutive patients who underwent left-sided Impella support for cardiogenic shock due to either acute myocardial infarction or decompensated heart failure. Patients who achieved 3-h post-Impella CPOi ⩾ 0.30 W/m2 were defined as Impella “hemodynamic responder.” Results: Twelve of the thirty-seven patients achieved 3-h post-impella CPOi  ⩾ 0.30 W/m2 (“hemodynamic responders”). Post-Impella CPOi correlated with 12-h lactate ( r = −0.779, p < 0.001) and lactate clearance ( r = 0.747, p < 0.001). “Hemodynamic responders” had lower 12-h lactate level and greater 12-h lactate clearance (52 (44–58) vs 17 (14–26)%, p < 0.001). Higher pre-Impella norepinephrine dose (−0.341, p = 0.003) and baseline lactate (−0.009, p = 0.003) were independently associated with lower 3-h post-Impella CPOi. Eighteen patients died within 30 days (2/12 “hemodynamic responders” compared to 16/25 “non-responders,” p < 0.001). Conclusion: Patients who achieved early 3-h post-Impella CPOi of ⩾0.30 W/m2 have greater lactate clearance and better short-term survival. Early post-Impella CPOi of 0.30 W/m2 may be used as a therapeutic goal and define favorable response to Impella in cardiogenic shock.

Publisher

SAGE Publications

Subject

Biomedical Engineering,Biomaterials,General Medicine,Medicine (miscellaneous),Bioengineering

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Cardiac power output ratio: Novel survival predictor after percutaneous ventricular assist device in cardiogenic shock;ESC Heart Failure;2024-07-09

2. Hemodynamic management of cardiogenic shock in the intensive care unit;The Journal of Heart and Lung Transplantation;2024-07

3. The Physiology of Microaxial Ventricular Assist Devices;Hemodynamic Physiology in Advanced Heart Failure and Cardiogenic Shock;2024

4. Therapeutic Phases in the Cardiogenic Shock—Part 2—Optimization of Mechanical Circulatory Support;Hemodynamic Physiology in Advanced Heart Failure and Cardiogenic Shock;2024

5. Staging and Phenotyping of Cardiogenic Shock;Hemodynamic Physiology in Advanced Heart Failure and Cardiogenic Shock;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3